title: Editorial: Should We Treat Aging as a Disease? Academic, Pharmaceutical, Healthcare Policy, and Pension Fund Perspectives.
authors.affiliation: The Biogerontology Research FoundationOxford, UK; Insilico Medicine Inc.Baltimore, MD, USA; Laboratory of Regenerative Medicine, Federal Research and Clinical Centre of Pediatric Hematology, Oncology and ImmunologyMoscow, Russia.
authors.forename: Alex
authors.initials: A
authors.lastname: Zhavoronkov
authors.affiliation: Insilico Medicine Inc.Baltimore, MD, USA; Radiation Ecology, Laboratory of Molecular Radiobiology and Gerontology, Institute of Biology of Komi Science Center of Ural Branch of RASSyktyvkar, Russia; Biological and Medical Physics Department, Moscow Institute of Physics and Technology (State University)Dolgoprudny, Russia.
authors.forename: Alexey
authors.initials: A
authors.lastname: Moskalev
keywords: ICD-11; WHO; aging disease; biogerontology; geroprotectors; longevity risk